GTG Labs - מכפיל שווי פעילות להכנסות GENE

Genetic Technologies leads in preventive diagnostics, creating unique GeneType tests for the early detection of diabetes and cancer. The EV/Sales history confirms the market valuation of assets, where the indicator determines the status of the value-to-revenue parameter. Revenue growth is driven by personalized medicine and expansion in Europe, while streamlined courier logistics ensure the prompt delivery of biomaterials.
פילוחי מדדים פיננסיים ומדדי שוק עבור Genetic Technologies Limited (GENE)

Genetic Technologies' high concentration of scientific personnel and unique R&D potential create a foundation for growth in operating revenues from precision diagnostics. The ratio of Enterprise Value to revenue, reflected on this EV/Sales multiplier chart, allows for an assessment of the market value of assets excluding debt, where a sharp vertical spike in the line warns the investor of an overbought asset and the risk of a speculative bubble.